Navigation Links
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
Date:11/27/2009

PARIS, November 27 /PRNewswire-FirstCall/ -- Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.

Oralair(R) is now registered in Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, and Spain. All the countries in which Stallergenes filed its application have approved it.

Oralair(R) is an immunotherapy tablet aimed at patients suffering from severe rhinoconjunctivitis caused by grass pollens, inadequately controlled using symptomatic treatments (antihistamines, corticosteroids).

"The European registration of Oralair(R) is a major milestone for Stallergenes. It confirms the evolution of immunotherapy towards EBM-documented, well-tolerated treatments, effective from the very first season. Immunotherapy tablets now share the same level of recognition as conventional pharmaceuticals and form a new therapeutic class: allergens. The next step is to implement the price and reimbursement assessment procedures prior to the launch country by country," says Albert Saporta, Chairman and CEO of Stallergenes.

About Oralair(R)

The Oralair(R) active substance consists of a set of pollens corresponding to the epidemiological characteristics of patient exposure in Europe: perennial rye grass (Lolium perenne), meadow grass (Poa pratensis), timothy grass (Phleum pratense), cocksfoot (Dactylis glomerata) and sweet vernal grass (Anthoxanthum odoratum).

From the outset, its clinical development has taken into account the benefit to patients: proven efficacy, safety, ease of use, compliance, and cost-containment through a pre- and coseason
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
2. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
3. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
4. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
5. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
6. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
7. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
8. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
9. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
10. Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
11. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... , March 30, 2015 ... biological drugs to treat cancer, viral infections and ... Sir John Bell , the Regius Professor ... the Office for the Strategic Coordination of Health ... effect.      (Photo: http://photos.prnewswire.com/prnh/20150330/736483 ...
(Date:3/30/2015)... TOKYO and MADISON, Wis. ... Shigehiro Nakajima ,) (TSE: 4901) ("Fujifilm") and Cellular ... (NASDAQ: ICEL ) ("CDI"), a leading developer and ... to precise specifications, today announced that the two companies ... acquire CDI via an all-cash tender offer to be ...
(Date:3/29/2015)... 29, 2015 Caris Life Sciences® ... data showing the presence of PD-1 and ... samples. Using Caris Molecular Intelligence®, the company,s ... expression of programmed cell death protein-1 (PD-1) ... while its ligand (PD-L1) expression was variable ...
Breaking Biology Technology:Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4
... Mass., April 27, 2012  X-BODY BioSciences, Inc., a developer ... novel methods of selecting for antibodies against targets on ... Summit (PEGS) and the associated Biologics Partnering Forum being ... Richard Wagner, Ph.D., Co-Founder and Executive ...
... Inc., a privately-held biotech company using its proprietary platform ... of gastrointestinal diseases, announced today that it has elected ... Pharmaceuticals, Inc. to its Board of Directors. ... serve on our Board," said Dr. Barbara Fox, founder, ...
... April 26, 2012 Europe,s premier biotech ... OBN, the not-for-profit business network which provides ... South-East England biocluster and beyond, today announced the results ... Held from April 24 - 26 at Newbury Racecourse, ...
Cached Biology Technology:X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit 2Avaxia Biologics Elects Christopher Kiritsy to its Board of Directors 2Another Record Year for BioTrinity 2Another Record Year for BioTrinity 3
(Date:3/18/2015)... March 18, 2015 As mobile payments ... revolutionary smart wallets and apps continue to be introduced into ... in the mobile payment industry in focus today are:  NXT-ID, ... (NYSE: BABA ), Apple Inc. (NASDAQ: ... Facebook Inc. (NASDAQ: FB ) NXT-ID, ...
(Date:3/12/2015)... IriTech, a leading iris based identity management ... Instruments Design Network, announced today that the Chief Minister ... USB MK2120U device during a launching event of Andhra ... The iris scanner is manufactured by U.S. ... India through its Indian partner, Biometronic ...
(Date:3/11/2015)... 11, 2015   The Sync Project™ ... scientifically measure and harness music to improve health. ... and objective measurements of physiology, enabling the study ... in large populations. It is designed for medical ... perform rigorous studies and accelerate the discovery of ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... that the dinosaurs and most their contemporaries were not ... to a paleontologist who says multiple meteor impacts, massive ... end of the Cretaceous Period. , The Chicxulub ... earlier of a series of meteors and volcanic eruptions ...
... the explosive growth in size and complexity of the human ... genes expressed in brain tissue has actually slowed since the ... international research team reports in the December 26, 2006, issue ... the human brain, the authors maintain, has not been driven ...
... years of research, scientists at The University of Texas M. ... exquisite molecular detail, how the estrogen hormone can help keep ... of the journal, Nature Cell Biology, they assign roles to ... part in breast cancer cell survival, and in the process, ...
Cached Biology News:Far more than a meteor killed dinos 2Far more than a meteor killed dinos 3Complexity constrains evolution of human brain genes 2Complexity constrains evolution of human brain genes 3New path from estrogen to survival in breast cancer cells described 2New path from estrogen to survival in breast cancer cells described 3
... ATPase α-1, clone C464.6 GenBank Accession ... Na + /K + ATPase isolated ... medulla Formulation: 0.1M Tris-glycine, pH 7.4, 0.15M ... routinely evaluated in immunoblot on rat brain ...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
EDG-1CT (endothelial cell differentiation gene-1, C terminal)...
Request Info...
Biology Products: